undefined undefined
NaN.000
NaN.00%
Evercore ISI launched its coverage with a bullish view on a number of biotech stocks on Tuesday, citing a more constructive view on the sector, which is seeing signs of recovery after years of underpe...
05-14 23:24
Wells Fargo analyst Mohit Bansal maintained a Buy rating on Neurocrine (NBIX – ...
05-14 06:47
Voyager Therapeutics is up ~8% in after-hour trading Monday after reporting Q1 financial results that beat on the top and bottom lines. In the quarter, the company swung to a loss of $11.3M from net i...
05-14 05:41
Last week saw the newest quarterly earnings release from Neurocrine Biosciences...
05-03 19:35
Unity Software(U.US) reported fourth-quarter financial results after the market...
05-03 01:59
Neurocrine (NASDAQ:NBIX) released a Q1 earnings report that beat Street revenue estimates, the day after announcing the FDA had approved an easier-to-swallow formulation of its drug Ingrezza. Early We...
05-02 00:47
Needham analyst Ami Fadia has maintained their neutral stance on NBIX stock, gi...
05-01 20:18
Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $1.20 per share which beat the analyst consensus estimate of $1.01 by 18.81 percent. This is a 335.29 percent increase over losses of $(0.51) per share
05-01 19:06
INGREZZA® (valbenazine) First Quarter Net Product Sales of $506 Million Representing 23% Year-Over-Year Growth INGREZZA® SPRINKLE (valbenazine) Capsules Approved by the U.S. FDA Crinecerfont...
05-01 19:00